From Name:
From Email:
To Name:
To Email:

Optional Message:

Takeda drug impresses in ulcerative colitis study

from Reuters

More than 40 percent of patients with moderate to severe ulcerative colitis achieved clinical remission from the debilitating condition after a year of taking an experimental drug developed by Japan's Takeda Pharmaceutical, according to data from a pivotal late-stage trial. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063